Results 21 to 30 of about 3,285 (205)
Role of the pfmdr1 Gene in Plasmodium falciparum Resistance to Antimalarial Treatment [PDF]
Plasmodium falciparum is an intracellular protozoan that causes the most severe form of malaria. A major hindrance to disease control efforts is the spread of drug resistant parasite populations, which has been linked to the Plasmodium falciparum multidrug resistance (pfmdr1) gene.
Bohorquez, Elaine Brooks
openaire +2 more sources
Background There are concerns that resistance to artemisinin-based combination therapy might emerge in Kenya and sub-Saharan Africa (SSA) in the same pattern as was with chloroquine and sulfadoxine–pyrimethamine. Single nucleotide polymorphisms (SNPs) in
Peninah Muiruri +11 more
doaj +2 more sources
Study’s Excerpt: • fmdr1 gene mutations were assessed in falciparum from pediatric malaria patients in Kano. • Only 3.2% of amplified samples showed the pfmdr1 N86Y mutation linked to drug resistance.
Ummukulsum Mustapha +9 more
doaj +4 more sources
Molecular Method Optimization to Identify Plasmodium falciparum Multidrug Resistance 1 (pfmdr1) gene as a Predictor of Antimalarial Resistance [PDF]
Several approaches have been designed to control malaria, a disease with high morbidity and mortality, but they face some hurdles. Antimalarial resistance is one of the major challenges for malaria elimination, so the detection of antimalarial resistance
Erma Sulistyaningsih +7 more
doaj +2 more sources
Background Malaria in pregnancy is associated with considerable morbidity and mortality. Regular surveillance of artemisinin-based combination therapy tolerance, or molecular makers of resistance, is vital for effective malaria treatment, control and ...
Louis Regis Dossou-Yovo +7 more
doaj +1 more source
Different patterns of pfcrt and pfmdr1 polymorphism in Plasmodium falciparum isolates from Tehama region, Yemen [PDF]
Introduction. Despite the efforts of the malaria control programme, malaria morbidity is still a common health problem in Yemen, with 60% of the population at risk. Plasmodium falciparum is responsible for 99% of malaria cases.
Wahib M. Atroosh +13 more
doaj +2 more sources
Artemisinin-based combination therapies (ACTs) have been vital in reducing malaria mortality rates since the 2000s. Their efficacy, however, is threatened by the emergence and spread of artemisinin resistance in Southeast Asia.
Carla Calçada +9 more
doaj +1 more source
Chemo‐proteomics in antimalarial target identification and engagement
Abstract Humans have lived in tenuous battle with malaria over millennia. Today, while much of the world is free of the disease, areas of South America, Asia, and Africa still wage this war with substantial impacts on their social and economic development.
Brodie L. Bailey +3 more
wiley +1 more source
Abstract Introduction The World Health Organization recommends regular monitoring of the efficacy of nationally recommended antimalarial drugs. We present the results of studies on the efficacy of recommended antimalarials and molecular markers of artemisinin and partner resistance in Afghanistan, Pakistan, Somalia, Sudan and Yemen.
Mariam Adam +32 more
wiley +1 more source
Lack of multiple copies of pfmdr1 gene in Papua New Guinea [PDF]
We describe here the results of an analysis of Plasmodium falciparum multidrug resistance protein 1 (pfmdr1) gene copy number from 440 field isolates from Papua New Guinea. No multiple copies of the gene were found, which corresponds to the lack of usage of mefloquine. These data extend regional knowledge about the distribution of multidrug-resistant P.
Hodel EM +9 more
openaire +3 more sources

